Traduction de «Analyser des comportements nocifs pour la santé » (Français → Anglais) :

As regards general criteria, we can differentiate between criteria based on scientific analysis (in principle the Community rules are based on sustainable development and so all fisheries would comply with this particular criterion), criteria relating to limiting the impact on the environment and ecosystem (which would involve looking at more selective production methods) and finally criteria relating to food safety (i.e. that they do not represent a danger to health).

N. whereas there is a lack of detailed and comparable statistics on the health services" ability to meet the need to ensure access to adequate medical care for everyone, and whereas it is important to assess the practices followed in the Member States, to analyse the behaviour of citizens in terms of seeking or failing to seek treatment, and to obtain comparable data which can inform policy-making at national and European level,

The Commission's Programme includes a commitment to working with the World Health Organization, the World Intellectual Property Organization and the World Trade Organization to address the link between TRIPS and health issues.

The report also looks into patterns of soft and hard drugs use, sexually transmitted diseases and mental health.

Q-91 Mr. Cummins (Delta South Richmond) With reference to the antimalarial drug mefloquine administered to Canadian Forces bound for Somalia in 1992-93 and the legal framework under which it was available for use and administered: (a) was mefloquine a licensed drug when it was administered to Canadian Forces, if not what was its status, and how was it legally available; (b) were the Canadian Forces participating in the Lariam (mefloquine) Safety Monitoring Study during this period; (c) was the mefloquine administered in accordance with the Lariam Safety Monitoring Study and the Food and Drugs Act; (d) who was the " principal investigator" responsible for the Lariam Safety Monitoring Study in the Canadian Forces; (e) who was the Canadia ...[+++]n Forces physician responsible to the " principal investigator" of the Lariam Safety Monitoring Study; (f) what was the role of Canadian Forces physician, Dr. Martin Tepper, in the Lariam Safety Monitoring Study; (g) who was responsible for the Lariam Safety Monitoring Study at the Department of Health's Health Protection Branch during this period; (h) what was the role and responsibility of the Health Protection Branch under the Lariam Safety Monitoring Study and the Food and Drugs Act and its regulations in regard to the use of mefloquine by Canadian Forces personnel; (i) when did the Health Protection Branch become aware that mefloquine was being administered to Canadian Forces personnel bound for Somalia; (j) what responsibility did the Canadian Forces have under the Lariam Safety Monitoring Study and the Food and Drugs Act prior to the licensing of mefloquine to inform the manufacturer of its use; (k) what responsibility did the Canadian Forces have under the Lariam Safety Monitoring Study and the Food and Drugs Act to the soldiers who were administered the drug; (l) did the Canadian Forces fulfil their responsibility to the manufacturer under the Lariam Safety Monitoring Study and the Food and Dru ...

Initiated in 1993, PAMP consisted of the following three components: an Adverse Drug Experience (ADE) reporting system, analysis of state antibiotic drug residue data, and a health evaluation of 28 commercial dairy herds.